ARTICLE | Clinical News
Sanguinate regulatory update
April 13, 2015 7:00 AM UTC
Prolong said FDA granted Orphan Drug designation to Sanguinate to treat sickle cell disease (SCD). Sanguinate is a pegylated carboxyhemoglobin bovine that functions as a carbon monoxide-releasing mole...